These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2467012)

  • 1. Obstructive uropathy in patients with benign prostatic hyperplasia.
    Sarmina I; Resnick MI
    J Urol; 1989 Apr; 141(4):866-9. PubMed ID: 2467012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostatic enlargement.
    Blandy J
    Practitioner; 1989 Apr; 233(1466):512-7. PubMed ID: 2481304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of bladder outlet obstruction and detrusor contractility on residual urine in patients with benign prostatic hyperplasia.
    Zhang P; Wu Z; Gao J
    Chin Med J (Engl); 2003 Oct; 116(10):1508-10. PubMed ID: 14570611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urodynamic risk factors for renal dysfunction in men with obstructive and nonobstructive voiding dysfunction.
    Comiter CV; Sullivan MP; Schacterle RS; Cohen LH; Valla SV
    J Urol; 1997 Jul; 158(1):181-5. PubMed ID: 9186351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary flow rate in benign prostatic hypertrophy.
    Anikwe RM
    Int Surg; 1976 Feb; 61(2):109-11. PubMed ID: 56317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benign prostatic hyperplasia (BHP) and bothersome voiding symptoms.
    Hald T
    J Urol (Paris); 1995; 101(1):7-9. PubMed ID: 7545735
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum creatinine measurements in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    Gerber GS; Goldfischer ER; Karrison TG; Bales GT
    Urology; 1997 May; 49(5):697-702. PubMed ID: 9145973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urodynamic study of obstructive uropathy due to benign prostatic hyperplasia].
    Fedel V; Povrzanović I; Fedel I
    Lijec Vjesn; 1992; 114(9-12):259-61. PubMed ID: 1285282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of intravesical prostatic protrusion and resistive index is useful to predict bladder outlet obstruction in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Suzuki T; Otsuka A; Ozono S
    Int J Urol; 2016 Nov; 23(11):929-933. PubMed ID: 27545297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical guidelines for male lower urinary tract symptoms and benign prostatic hyperplasia.
    Homma Y; Gotoh M; Kawauchi A; Kojima Y; Masumori N; Nagai A; Saitoh T; Sakai H; Takahashi S; Ukimura O; Yamanishi T; Yokoyama O; Yoshida M; Maeda K
    Int J Urol; 2017 Oct; 24(10):716-729. PubMed ID: 28748576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the bladder wall muscle associated with benign prostatic enlargement. A clinical and morphometric study.
    Jakse G; Hoffstädter F
    Urol Res; 1977; 5(3):149-52. PubMed ID: 72445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptomatology and diagnosis of benign prostatic hyperplasia.
    Pavone-Macaluso M
    Eur Urol; 1991; 20 Suppl 1():41-3. PubMed ID: 1722161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations between clinical findings and urinary flow rate in benign prostatic hypertrophy.
    Anikwe RM
    Int Surg; 1976 Aug; 61(8):392-4. PubMed ID: 61184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased urinary nerve growth factor reflects prostatic volume reduction and relief of outlet obstruction in patients with benign prostatic enlargement treated with dutasteride.
    Wada N; Matsumoto S; Kita M; Hashizume K; Kakizaki H
    Int J Urol; 2014 Dec; 21(12):1258-62. PubMed ID: 25039474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal protein metabolism in obstructive uropathy.
    Novakovic L; Hall PW; Persky L
    J Urol; 1975 Mar; 113(3):389-91. PubMed ID: 46927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of transrectal ultrasonographic findings of the prostate with the occurrence of detrusor instability in patients with benign prostatic hyperplasia.
    Tong YC; Lin YM; Yang WH; Tzai TS; Lin JS
    Urol Int; 1995; 55(3):154-7. PubMed ID: 8540161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photoselective vaporization of the prostate: a volume reduction analysis in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia and carcinoma of the prostate.
    Kumar SM
    J Urol; 2005 Feb; 173(2):511-3. PubMed ID: 15643231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia.
    Oelke M; Baard J; Wijkstra H; de la Rosette JJ; Jonas U; Höfner K
    Eur Urol; 2008 Aug; 54(2):419-26. PubMed ID: 18325657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The outcome of renal ultrasound in the assessment of 556 consecutive patients with benign prostatic hyperplasia.
    Koch WF; Ezz el Din K; de Wildt MJ; Debruyne FM; de la Rosette JJ
    J Urol; 1996 Jan; 155(1):186-9. PubMed ID: 7490828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.